Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price54.65 USD
Fair value53.12
Ethical score70.0/100
Our investment reviews on this name
2026-07-02Read Accumulation37.78+44.7% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Andersen Group Inc. holds its Accumulation at $54.65. The statistical read favours the sellers, held for 2 days.
As held on the ledger · 2026-09-21
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 2 days
Price at the screen
$54.65
Valuation
121.44 trailing · 23.93 forward price to earnings
Values screen
FAIL· score 70.0
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
81.49%
Below 33%
Interest-bearing debt is 81.5% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
1.45%
Below 33%
Cash held in interest-bearing accounts and securities is 1.4% of assets, under the one-third limit.
Pass
Receivables
66.12%
Below 49%
Money owed to the company is 66.1% of assets, above the 49% limit.
Fail
Revenue purity
0.50%
Below 5%
Only 0.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Andersen's business is in a permissible area, but its interest-bearing debt is about 81% of the company, well over the ~33% line, so it does not pass on the financial screens. Its receivables are also high.
Read as at 2026-10-03. It updates when the underlying figures move, and past reads are kept below.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 2.8% above the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits +2% from the screen price.
Reading the gap · Our model and the Street both land near the screened price: fairly valued, with no strong edge either way.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Tax advice firm losing money at a premium price
Picture a firm that helps wealthy clients dodge tax headaches, yet cannot keep its own books in the black. Andersen Group shows 16% revenue growth but posts a 6% negative profit margin and a 145% negative return on equity. At $44.45 against a fair value of $41.58 the shares already sit above what the numbers support, which is why the opportunity rating sits at none despite an ethical screen pass.
Analyst chatter calls it a buy with a $42 median target, yet forward earnings sit on a 20.3 times multiple for a business that is currently destroying capital. The personal services sector adds cyclical pressure that can swing quickly when client wallets tighten. Unknown competitive edge leaves little cushion if rivals cut fees or win mandates.
The combination of deep losses, stretched valuation and no clear moat outweighs the revenue line and clean ethics check. We pass.
Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ANDG trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-02Accumulation$54.65+1.9%Entry 8
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40.
2026-09-21Accumulation$53.65+8.0%Entry 7
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40.
2026-08-21Accumulation$49.68+11.8%Entry 6
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 11.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40.
2026-07-21Accumulation$44.45+17.7%Entry 5
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 17.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40.
2026-07-18Accumulation$37.78+0.0%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40.
2026-07-17Accumulation$37.78+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 53%. The street (6 analysts) rates it buy, with a mean price target of $40.
2026-07-03Accumulation$37.78+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Accumulation$37.78Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.